Is Pseudomonas Infection Associated with Worse Outcomes in Pediatric Perforated Appendicitis?
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Nov 2020 · 1 min read
In brief
In brief
Retrospective study of 255 pediatric perforated appendicitis cases found Pseudomonas in 22% of intraoperative cultures but no increased risk of surgical site infections compared to non-Pseudomonas cases. Despite longer antibiotic courses and hospital stays, similar complication rates suggest empiric Pseudomonas coverage may be unnecessary in this population.
Written by the GCMD Library team from the article.
Abstract
Background
There is little information on the effects of Pseudomonas infection on outcomes in perforated appendicitis. As Pseudomonas is not covered by many empiric appendicitis antibiotic regiments, we hypothesized that children with Pseudomonas would have worse outcomes.
Methods
Patients <18 years old undergoing appendectomy for perforated appendicitis at a tertiary children's hospital 2015–2019 were included and were stratified by presence of Pseudomonas on intraoperative culture. The primary outcome was post-operative organ-space infection (SSI).
Results
Intraoperative cultures were collected in 58.4% of patients (n = 149/255) with 22.2% (n = 33) positive for Pseudomonas. SSIs occurred in 21.2% of children with Pseudomonas compared to 20.7% of children without Pseudomonas (p = 0.9). Children with Pseudomonas had longer antibiotic duration (9.1 vs. 6.7 days, p = 0.03) and LOS (6.7 vs. 5.9 days, p = 0.03) than those without, but a similar rate of post-operative interventions (12.2% vs. 19.0%, p = 0.4), hospital costs ($28,860 vs. $23,945, p = 0.3), ED visits (9.1% vs. 19.9%, p = 0.3), and readmissions (9.1% vs. 9.5%, p = 1).
Conclusion
Pseudomonas was identified in 22% children with perforated appendicitis and was associated with longer antibiotic durations and LOS, but similar rates of SSI, post-operative interventions, and readmissions compared to children without Pseudomonas. Empiric coverage of Pseudomonas may not be necessary.